Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials